Chief Strategy Officer and Senior Vice President of Corporate Development
Kyle Salyers joined Health Catalyst in 2014 and serves as Chief Strategy Officer and Senior Vice President of Corporate Development. Prior to joining Health Catalyst, he was a Co-Founder and the Managing Director of CHV Capital, a venture capital affiliate of Indiana University Health. In addition to Health Catalyst, Kyle led CHV/ Indiana University Health’s investments in a range of healthcare IT and medical device companies, including MedVentive (acquired by McKesson), MindFrame (acquired by Covidien), Perfect Serve, NICO, NeoChord, Par8o, and Celleration. Prior to CHV Capital, he served in a number of leadership positions across government, academia, and in entrepreneurial companies, including as a Special Advisor to the President of Indiana University & Executive Director for Advancing Indiana, Investment Director & Innovation Fellow at Rose-Hulman Ventures and the Rose-Hulman Institute of Technology, Senior Vice President of Thomas P. Miller and Associates, Vice President of the Indiana Technology Partnership, and Economic Development Manager for the City of Indianapolis, Mayor Stephen Goldsmith.
